Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The FDA approved Binimetinib + Encorafenib for adult patients with metastatic Non-small cell lung cancer (NSCLC) (BRAF m) confirmed by an FDA-approved test.FoundationOne CDx and FoundationOne Liquid CDx are approved as companion diagnostics for this indication (1)
EMA/EU also approved this treatment setting (2)
Based on NCT03915951, in patients with treatment-naive and previously treated metastatic Non-small cell lung cancer (NSCLC) (BRAF m), the co…